Published in Medical Verdicts and Law Weekly, June 7th, 2007
Study 1: A new study, "Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis," is now available. According to a study from Thessaloniki, Greece, "There is indirect evidence of unfavorable effects of parathyroid hormone (PTH) on glucose metabolism. Teriparatide (recombinant human PTH 1-34-TPTD) has recently been available for the treatment of osteoporosis."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.